These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9516378

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R, McGlave PB, Miller JS, Wissink S, Lin WN, Verfaillie CM.
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative effects of suppressive cytokines on isolated single CD34(3+) stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum.
    Lu L, Xiao M, Grigsby S, Wang WX, Wu B, Shen RN, Broxmeyer HE.
    Exp Hematol; 1993 Oct; 21(11):1442-6. PubMed ID: 7691634
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.
    Clemons MJ, Marshall E, Dürig J, Watanabe K, Howell A, Miles D, Earl H, Kiernan J, Griffiths A, Towlson K, DeTakats P, Testa NG, Dougal M, Hunter MG, Wood LM, Czaplewski LG, Millar A, Dexter TM, Lord BI.
    Blood; 1998 Sep 01; 92(5):1532-40. PubMed ID: 9716580
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
    Clemons M, Watson A, Howell A, Chang J, Heyworth C, Lord B, Testa N, Dexter TM, Margison G.
    Clin Cancer Res; 2000 Mar 01; 6(3):966-70. PubMed ID: 10741722
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model.
    Cashman JD, Clark-Lewis I, Eaves AC, Eaves CJ.
    Blood; 1999 Dec 01; 94(11):3722-9. PubMed ID: 10572085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.